You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Johnson and Johnson
Harvard Business School
Mallinckrodt
McKinsey

Last Updated: February 28, 2020

DrugPatentWatch Database Preview

CONZIP Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

When do Conzip patents expire, and what generic alternatives are available?

Conzip is a drug marketed by Cipher Pharms Inc and is included in one NDA. There is one patent protecting this drug.

This drug has three patent family members in three countries.

The generic ingredient in CONZIP is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.

Summary for CONZIP
International Patents:3
US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 8
Bulk Api Vendors: 73
Patent Applications: 1,540
Formulation / Manufacturing:see details
Drug Prices: Drug price information for CONZIP
DailyMed Link:CONZIP at DailyMed
Drug patent expirations by year for CONZIP
Drug Prices for CONZIP

See drug prices for CONZIP

Pharmacology for CONZIP
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Synonyms for CONZIP
( inverted exclamation markA)-cis-2-(Dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(+-)-cis-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(+-)-cis-2-((Dimethylamino)methyl)-1-(m-methoxyphenyl)cyclohexanol hydrochloride
(+)-(1R,2R)-Tramadol hydrochloride
(+)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(+)-Tramadol Hydrochloride
(+)-Tramadol,hydrochloride
(+)-trans-Tramadol Hydrochloride
(1R-cis)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
(1R,2R)-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride
(1R,2R)-2-(Dimethylaminomethyl)-1-(3-methoxyphenyl)-cyclohexanol hydrochloride
(1R,2R)-2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride
(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol;hydrochloride
(1R,2R)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
(1R,2R)-rel-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
(1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol
(1RS,2RS)-2-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexanol
(R,R)-tramadol hydrochloride
[(1R,2R)-2-hydroxy-2-(3-methoxyphenyl)cyclohexyl]-N,N-dimethylmethanaminium chloride
1-(m-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexane-1-ol
1109217-84-6
148229-78-1
194602-08-9
2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXAN-1-OL
2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
2-Dimethylaminomethyl-1-(m-methoxyphenyl)cyclohexanol
204T882
22204-88-2
2914-77-4
36282-47-0
53611-16-8
AB1009456
AC-796
AC1L1KJ8
AC1L1Y7D
AC1Q7AST
ACM2914774
Adolanta
AKOS015907739
AKOS022507395
Amadol
AN-15516
AN-32783
API0000067
API0004461
AX8154449
BC202864
BCP28607
Bellatram
C16H25NO2.HCl
CCG-101135
Cemadol
CG 315
CG-315E
CHEBI:75722
CHEBI:75733
CHEMBL1200336
CHEMBL1237044
cis-(+-)-E 383 hydrochloride
cis-(+/-)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride
cis-(+/-)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol Hydrochloride
cis-(1)-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride
cis-Tramadol hydrochloride
cis-Tramadol hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Contramal
COR0000099
CPD000449308
CS-2770
CTK4G2807
CTK8G3518
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, (1R,2R)-rel-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, cis-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, cis-( -)-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(3-methoxyphenyl)-, hydrochloride, cis-(+-)-
Cyclohexanol, 2-((dimethylamino)methyl)-1-(m-methoxyphenyl)-, hydrochloride, cis-(+-)-
Cyclohexanol, 2-(dimethylaminomethyl)-1-(m-methoxyphenyl)-
Cyclohexanol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-
Cyclohexanol,2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-
D01355
Dolana
DTXSID7023691
E 382
EINECS 220-831-4
EINECS 252-950-2
EINECS 258-662-3
FT-0638197
FT-0675345
FT-0675347
GTPL8286
HSDB 7047
HY-B0582A
I14-2711
Ira-Tramadol
Jsp004511
K-8120
KS-1124
L000985
LS-174590
LS-191406
LS-57112
LS-57113
LS-57114
LS-57120
Mabron
Maxitram
MCULE-1882520267
MCULE-3504250719
Melanate
MLS000758218
MLS001424208
NC00385
NIH 10969
Omnidol
Poltram
PPKXEPBICJTCRU-XMZRARIVSA-N
Q-201847
Radol
RT-015840
Rybix
Rybix ODT
Ryzolt
SAM001246847
SAM001247044
SC-77562
SCHEMBL41748
SCHEMBL57496
SMR000449308
SR-01000759320
SR-01000759320-5
Synapryn
Tadol
Tilodol
TL8001847
Trabar
Tradol-Puren
Tradonal
Tramadex
Tramadol HCl
Tramadol HCl; (+/-)cis-2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanolhydrochloride
tramadol hydrochloride
Tramadol hydrochloride (JAN/USAN)
Tramadol hydrochloride [USAN:JAN]
Tramadol hydrochloride [USAN:USP:JAN]
Tramadol Hydrochloride 1.0 mg/ml in Methanol (as free base)
tramadol hydrochloride tablets
Tramadol hydrochloride, >=98% (HPLC), solid
Tramadol hydrochloride, >=99.0% (HPLC)
Tramadol hydrochloride, British Pharmacopoeia (BP) Reference Standard
Tramadol hydrochloride, European Pharmacopoeia (EP) Reference Standard
Tramadol hydrochloride, United States Pharmacopeia (USP) Reference Standard
TRAMADOL/HCL
tramadole hydrochloride
Tramagetic
Tramal
Tramal Retard
Tramazac
Tramed
Tramol
trans-(+/-)-2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol hydrochloride
Tridol
Tridural
TVYLLZQTGLZFBW-UHFFFAOYSA-N
U 26,225A
U-26,225A
U-26225A
Ultram
Ultram (TN)
Ultram ER
UNII-9N7R477WCK component PPKXEPBICJTCRU-XMZRARIVSA-N
Viotra
W0081
Zumatran
Zydol
Zydol hydrochloride
Zydol XL 150

US Patents and Regulatory Information for CONZIP

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipher Pharms Inc CONZIP tramadol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370-001 May 7, 2010 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Cipher Pharms Inc CONZIP tramadol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370-003 May 7, 2010 RX Yes No   Start Trial   Start Trial Y   Start Trial
Cipher Pharms Inc CONZIP tramadol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370-004 Aug 1, 2011 RX Yes No   Start Trial   Start Trial   Start Trial
Cipher Pharms Inc CONZIP tramadol hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 022370-002 May 7, 2010 RX Yes No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Supplementary Protection Certificates for CONZIP

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0566709 C300152 Netherlands   Start Trial PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
0566709 SPC/GB04/012 United Kingdom   Start Trial PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Medtronic
McKinsey
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group

DrugPatentWatch reviews